Research note: ethics of drug treatment research with court-supervised subjects.
The last two decades have seen an acceleration of clinical research on, and treatment advances in, addictive illness. Much important research in this area requires the participation of subjects who themselves suffer from drug dependence and have a strong likelihood of becoming involved in the criminal justice system at some point. However, using court-supervised persons with addictive disorders in drug research raises a number of significant ethical issues. These include, among others, worries about the individual's ability to provide capable, voluntary, informed consent and the obligation of researchers to safeguard sensitive clinical information. A variety of potentially coercive factors can influence court-supervised persons in their decision whether to enter research and can compromise their ability to provide informed consent. In this paper, we explore the ethical issues arising in this research and offer some suggestions for approaches to address these concerns.
DuVal
Gordon
G
Centre for Addiction and Mental Health, University of Toronto Joint Centre for Bioethics, Department of Psychiatry, and Faculty of Law, University of Toronto, Canada.
Salmon
Christina
C
D000293:Adolescent; D003068:Coercion; D003219:Confidentiality; D003416:Criminal Law; D030881:Disclosure; D006805:Human Experimentation / Q000941:ethics*; D006801:Humans; D007258:Informed Consent; D035846:Law Enforcement; D016743:Mental Competency; D011287:Prejudice; D011329:Prisoners; D035842:Research Subjects; D019966:Substance-Related Disorders / Q000628:therapy; D014481:United States